Caris Life Sciences

Caris Life Sciences

Biotechnology Research

Irving, Texas 58,576 followers

Fulfilling the promise of precision medicine through quality and innovation.

About us

Caris Life Sciences® (Caris) is the leading next-generation TechBio company and precision medicine pioneer that is actively developing and delivering innovative solutions to revolutionize healthcare and improve the human condition. Through comprehensive molecular profiling (Whole Exome and Whole Transcriptome Sequencing) and the application of advanced artificial intelligence (AI) and machine learning algorithms, Caris has created the large-scale, clinico-genomic database and computing capability needed to analyze and unravel the molecular complexity of disease. This convergence of sequencing power, big data and AI technologies provides an unmatched platform to deliver the next-generation of precision medicine tools for early detection, diagnosis, monitoring, therapy selection and drug development. Headquartered in Irving, Texas, Caris has offices in Phoenix, New York, Tokyo, Japan and Basel, Switzerland. Caris or its distributor partners provide services in the U.S., Europe, Asia and other international markets.

Industry
Biotechnology Research
Company size
1,001-5,000 employees
Headquarters
Irving, Texas
Type
Privately Held
Founded
1996
Specialties
Biotechnology, Molecular Profiling, Genomics, Personalized Medicine, Diagnostics, Theranostics, Panomics, Precision Medicine, and Comprehensive Genomic Profiling

Locations

Employees at Caris Life Sciences

Updates

Similar pages

Browse jobs

Funding

Caris Life Sciences 5 total rounds

Last Round

Debt financing

US$ 400.0M

Investors

OrbiMed
See more info on crunchbase